Financials
- Market Capitalization 3.02 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-7.9
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1614 | CELC Celcuity Inc. - Common Stock | 63.53 USD | -3.52% | -10.87% | -23.78% | +35.29% | 3.11 B USD | ||
| 1615 | VKTX Viking Therapeutics, Inc. - Common Stock | 26.90 USD | -5.08% | -5.71% | -15.14% | -18.14% | 3.14 B USD | ||
| 1667 | ELVN Enliven Therapeutics, Inc. - Common Stock | 39.49 USD | -3.31% | -5.64% | -28.20% | +91.14% | 2.89 B USD | ||
| 1675 | DNLI Denali Therapeutics Inc. - Common Stock | 18.38 USD | -3.01% | -5.60% | -12.85% | +13.67% | 2.94 B USD |